Elion Therapeutics
- Business Model
- B2B
- Website
- eliontx.com
- Total Funding
- $81.0M
- Last Round
- $81.0M Series BJun 2024
- Rounds
- 1
About
Biotechnology company developing novel therapies to combat life-threatening invasive fungal infections.
Summary
Elion Therapeutics is a Biotech company. It has raised $81.0M in total across 1 round, most recently a $81.0M Series B round in Jun 2024. Investors include Deerfield Management, AMR Action Fund and Illinois Ventures.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2024
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company